3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
14
Sarcoma
11
Glioblastoma
11
Squamous Cell Carcinoma of Head and Neck
10
Rectal Neoplasms
8
Esophageal Neoplasms
8
Stomach Neoplasms
7
Urinary Bladder Neoplasms
6
Neoplasms
6
Carcinoma, Hepatocellular
6
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Hypopharyngeal Neoplasms
4
Head and Neck Neoplasms
4
Glioma
4
Colonic Neoplasms
4
Recurrence
3
Prostatic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Astrocytoma
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Cyclophosphamide
6
Platinum
5
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Surgical Procedures, Operative
×
1 year
×
Clear all
No trials found.